Research Summary
Dr. Dellon is an academic gastroenterologist with formal research training in epidemiology, clinical and translational research, and clinical trial design. He has led multidisciplinary research teams in eosinophilic esophagitis (EoE) and eosinophilic GI diseases (EGIDs). His research has focused on optimizing the diagnosis, characterizing the epidemiology, studying the pathogenesis, and refining the treatment and monitoring of EoE/EGIDs, with the overall goal of improving patient care and outcomes. He is well suited for his roles in the CGIBD for several reasons. First, he has advanced training and practical experience in clinical and translational research design and execution, including leading and participating in multicenter studies, biobanking, supervising complex data management and biostatistics needs, and managing a large group of clinical coordinators expert in all aspects clinical research and specimen procurement. Second, he has a broad research portfolio supported by independent funding. Third, he has published more than 400 peer-reviewed articles, more than 310 of which are related to EoE/EGIDs. In particular, he is the first author on both the 2013 ACG EoE guidelines and the 2018 international EoE diagnostic guidelines, senior author on the technical review informing 2020 AGA/JTF guidelines, first author on the 2022 EGID Nomenclature Consensus and 2022 EoE Severity Index and am leading development of the forthcoming 2023-2024 ACG guidelines.
CGIBD Focus Area(s): Clinical/Translational Research
Pilot and Feasibility Award 2010
Collaborators: Barnes, Barritt, Brenner, Blikslager, Fodor, Herfarth, Gray, Keku, Long, Moon, Peery, Sandler, Shaheen
